Vimarsana
Biggest News Aggregation in the World

Page 8 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Vimarsana News

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

03.02.2024 - SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) - Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the ...

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054 - Vimarsana News

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054

/PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of...

Vera Therapeutics Announces Pricing of Upsized Public - Vimarsana News

Vera Therapeutics Announces Pricing of Upsized Public

BRISBANE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and...

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock - Vimarsana News

Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock

BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...

Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering - Vimarsana News

Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering

Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the pricing of an underwritten offering...